|
|||||
|
|
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy |
|
| Authors: | Suzanne Leijen Sjaak A. Burgers Paul Baas Dick Pluim Matthijs Tibben Erik van Werkhoven Enzo Alessio Gianni Sava Jos H. Beijnen Jan H. M. Schellens |
| Affiliation: | 1. Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands 2. Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands 3. Department of Thoracic Oncology, Amsterdam Medical Center, Amsterdam, The Netherlands 4. Department of Pharmacy and Pharmacology, Slotervaart Hospital, Amsterdam, The Netherlands 5. Biometrics Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands 6. University of Trieste, Department of Chemical and Pharmaceutical Sciences, Trieste, Italy 7. Callerio Foundation Onlus, Via A. Fleming 22-31, 34127, Trieste, Italy 8. Department of Life Sciences, University of Trieste, Trieste, Italy 9. Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |